Microbiome Sequencing Services Market Research and Forecast Report 2023-2028

1. Global Microbiome Sequencing Services Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Microbiome Sequencing Services Market Research Report: The latest report by IMARC, titled “Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " the global microbiome sequencing services market reached a value of US$ 1,846.3 Million in 2022. Microbiome sequencing services assist in evaluating microflora in human biota to understand the function of microbes in human health and disease pathogenesis. They utilize next-generation sequencing (NGS) technologies to analyze microorganisms growing on saliva, oral mucosa, skin, conjunctiva, and gastrointestinal tract. Microbiome sequencing services are widely utilized for disease diagnosis and determining a patient’s response to a specific treatment. As compared to conventional microbiology methods, microbiome sequencing is more cost-effective, less labor-intensive, saves time, and provides faster and more accurate classifications. It is also capable of identifying low-abundant bacteria, characterizing non-cultivable bacteria, and profiling numerous microorganisms in a single analysis. Request Free Sample Report: https://www.imarcgroup.com/microbiome-sequencing-services- market/requestsample

4. Report Description and Highlights Report Description Global Microbiome Sequencing Services Market Trends: The rising consumer awareness about the advantages of early diagnosis and disease detection is one of the key factors driving the market growth. Microbiome sequencing services are widely used to understand the relationship between human pathogen and gut microbiome that assist in determining the health status and diagnosing infectious, inflammatory, immune, and obesity-related diseases. In addition, the rising prevalence of colorectal cancer (CRC) on account of the increasing geriatric population, proliferation of inflammatory intestinal conditions, and widespread consumption of low fiber and high-fat diet is acting as another growth-inducing factor. Furthermore, recent technological advancements in NGS, such as the introduction of nanopore sequencing technology and single- molecule real-time sequencing (SMRT) methods that enhance data yield, reduce amplification bias, and minimize costs, are providing a considerable boost to the market growth. Additionally, the integration of machine learning (ML) and artificial intelligence (AI) to interpret enormous microbiome data for improving diagnostic accuracy and predicting diseases is creating a positive outlook for the market. Moreover, the significant growth in the pharmaceutical industry and the increasing need to study drug-microbiome interaction for developing novel drugs, personalized medicines, and biomarkers are providing an impetus to the market growth. Other factors, including increasing investments in microbiome research, the significant development in the healthcare industry, and the rising service adoption in academia and research institutes for small molecule and protein analysis, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 5,568.4 Million by 2028, exhibiting a CAGR of 20% during 2023-2028. Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

5. Report Description and Highlights Report Description Market Summary: Breakup by Technology: • Sequencing by Synthesis (SBS) • Sequencing by Ligation (SBL) • Pyrosequencing • Sanger Sequencing • Others Breakup by Research Type: • Outsourced Research • Internal Research Breakup by Laboratory Type: • Dry Labs • Wet Labs Breakup by Application: • Shotgun Sequencing • Targeted Gene Sequencing

6. Report Description and Highlights Report Description • RNA Sequencing • Whole Genome Sequencing • Others Breakup by End User: • Pharmaceutical and Biotechnology Companies • Research and Academic Institutes • Others Breakup by Region: • North America • United States • Canada • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia

7. Report Description and Highlights Report Description • Others • Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

8. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • • BaseClear B.V. Clinical-Microbiomics A/S Diversigen Inc (OraSure Technologies Inc.) Mérieux NutriSciences Metabiomics Corporation (BioSpherex LLC) Microbiome Insights Inc. Microbiome Therapeutics LLC Molecular Research LP Molzym GmbH & Co. KG Resphera Biosciences LLC Shanghai Realbio Technology (RBT) Co. Ltd. Zymo Research Corporation View Full Report with TOC & List of Figure: https://www.imarcgroup.com/microbiome-sequencing- services-market

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com